HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by VandeVoort, C. A. Articles by Stewart, D. R. Search for Related Content PubMed PubMed Citation Articles by VandeVoort, C. A. Articles by Stewart, D. R. Agricola Articles by VandeVoort, C. A. Articles by Stewart, D. R.

Effects of Progesterone Receptor Blockers on Human Granulosa-Luteal Cell Culture Secretion of Progesterone, Estradiol, and Relaxin¹

^a California Regional Primate Research Center, ^b Division of Reproductive Biology, ^c Department of Ob/Gyn and Institute of Toxicology and Environmental Health, University of California, Davis, California 95616

We have developed culture methods for human luteinizing granulosa cells (GLC) that support the timely and dynamic secretion of estrogen (estradiol-17ß; E₂), progesterone (P₄), and relaxin (Rlx) in patterns that mimic serum hormone concentrations during the luteal phase of the menstrual cycle. Additional hCG, to simulate rescue of the corpus luteum, prevented the normal decline in GLC hormone production. To test the importance of the P₄ receptor in P₄ production, GLC were treated in vitro with two P₄ receptor antagonists. Human GLC received one of two hCG support protocols: a Baseline group simulating the normal luteal phase or a Rescue group simulating early pregnancy. Baseline and Rescue groups were treated with either RU-486 or HRP2000 either early or late in the cell culture period. The effects of treatments or control on ovarian steroid and peptide hormone production were determined (significant difference was P < 0.05). In the Rescue group, late treatment resulted in an immediate and dramatic decline in E₂, P₄, and Rlx secretion to nearly nondetectable levels within 1 day after treatment, and hormones remained depressed for the remaining 10 days of culture. In contrast, early treatment resulted in a decline in steroid hormone secretion that returned to control levels within 5 days of cessation of treatment, and Rlx secretion was delayed for approximately 5 days more than in controls. The data support the hypothesis that P₄ may be a required autocrine factor, not only for its own production but also for the maintenance of full endocrine function of the corpus luteum.

First decision: 1 September 1998.

¹ Supported in part by National Institutes of Health Grants ESO 6198 and P51-RR00169 and a grant from the Andrew W. Mellon Foundation.

² Correspondence. FAX: 530 752 2880; cavandevoort{at}ucdavis.edu

This article has been cited by other articles:

				L. Engmann, R. Losel, M. Wehling, and J. J. Peluso Progesterone Regulation of Human Granulosa/Luteal Cell Viability by an RU486-Independent Mechanism J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4962 - 4968. [Abstract] [Full Text] [PDF]

				C. P. Houk, E. J. Pearson, N. Martinelle, P. K. Donahoe, and J. Teixeira Feedback Inhibition of Steroidogenic Acute Regulatory Protein Expression in Vitro and in Vivo by Androgens Endocrinology, March 1, 2004; 145(3): 1269 - 1275. [Abstract] [Full Text] [PDF]

				C.L. Swan, M.C. Agostini, P.M. Bartlewski, V. Feyles, R.J. Urban, and P.J. Chedrese Effects of Progestins on Progesterone Synthesis in a Stable Porcine Granulosa Cell Line: Control of Transcriptional Activity of the Cytochrome P450 Side-Chain Cleavage Gene Biol Reprod, April 1, 2002; 66(4): 959 - 965. [Abstract] [Full Text] [PDF]